Supplementation | ||||
---|---|---|---|---|
Parameter | Visit | 250 IU/day (n=14) | 500 IU/day (n=14) | p Value: 250 vs 500 IU |
Gestation (weeks) | 39 (39–40) | 39 (39–40) | 0.63 | |
Weight (g) | Day 5 | 3763 (3492–3854) | 3584 (3332–3835) | 0.32 |
6 weeks | 4768 (4444–5092)* | 4195 (3882–4509)* | 0.02 | |
Length (cm) | Day 5 | 52 (51–53) | 52 (51–53) | 0.69 |
6 weeks | 58 (57–59) | 56 (55–57) | 0.02 | |
25(OH)D (nmol/l) | Day 5 | 68 (53–83) | 68 (53–83) | 0.99 |
6 weeks | 139 (114–164)* | 151 (126–176)* | 0.48 | |
Alkaline phosphatase (U/l) | Day 5 | 320 (276–378) | 348 (300–396) | 0.48 |
6 weeks | 858 (720–996)* | 888 (750–1026)* | 0.78 | |
Calcium (mmol/l) | Day 5 | 2.38 (2.29–2.47) | 2.38 (2.29–2.47) | 0.99 |
6 weeks | 2.66 (2.58–2.73)* | 2.55 (2.47–2.62)* | 0.048 | |
Phosphate (mmol/l) | Day 5 | 2.0 (1.9–2.2) | 2.0 (1.9–2.2) | 0.85 |
6 weeks | 2.2 (2.1–2.2) | 2.1 (2.1–2.2) | 0.33 | |
Creatinine (μmol/l) | Day 5 | 38.4 (29.1–47.6) | 38.3 (29.3–47.3) | 0.1 |
6 weeks | 37.7 (31.6–43.8) | 26.8 (19.9–32.2)* | 0.01 | |
U-calcium (mmol/l) | Day 5 | 0.43 (0.1–0.75) | 0.55 (0.25–0.86) | 0.6 |
6 weeks | 1.54 (0.82–2.3)* | 1.45 (0.75–2.15)* | 0.85 | |
U-phosphate (mmol/l) | Day 5 | 4.9 (0.85–8.9) | 2.83 (1.0–6.8) | 0.46 |
6 weeks | 3.3 (0.3–6.8) | 4.8 (1.4–8.2) | 0.52 | |
U-creatinine | Day 5 | 4621 (2673–6569) | 5194 (3346–7042) | 0.67 |
6 weeks | 769 (337–1201)* | 1062 (646–1478)* | 0.32 | |
Ca/creatinine ratio | Day 5 | 159 (68–250) | 145 (59–231) | 0.82 |
6 weeks | 1823 (1353–4999)* | 3898 (838–6959)* | 0.34 | |
Sun exposure/day (h) | 2.1 (1.6–2.6) | 1.8 (1.3–2.4) | 0.47 | |
Sun exposure score | 2.1 (1.8–2.4) | 1.6 (1.3–1.9) | 0.048 | |
UVB exposure (MED/day) | 0.05 (0.02–0.08) | 0.03 (0.01–0.06) | 0.37 |
Data are presented as mean and 95% CI. p Values refer to the comparison of daily supplementation with 250 vs 500 units of vitamin D3.
↵* Represent a significant difference between time points (day 5 vs 6 weeks, p<0.05).
MED, minimal erythema dose; UVB, ultraviolet B.